Concepedia

Publication | Open Access

Docetaxel, Oxaliplatin, and 5-Fluorouracil (DOF) in Metastatic and Unresectable Gastric/Gastroesophageal Junction Adenocarcinoma: A Phase II Study with Long-Term Follow-Up

DOIFull Paper Access

22

Citations

12

References

2019

Year

Ari J. Rosenberg, Alfred Rademaker, Howard S. Höchster, Theresa Ryan, Thomas A. Hensing, Veena Shankaran, Lisa Baddi, Devalingam Mahalingam, Mary F. Mulcahy, Al B. Benson
The Oncologist

Abstract

DOF demonstrates a high response rate, expected safety profile, and prolonged survival and remains an option for select patients with unresectable or metastatic gastric or GEJ adenocarcinoma.

References

YearCitations

Page 1